DOI: http://dx.doi.org/10.18203/2349-2902.isj20185016

In the era of endo-venous ablation of varicose veins, is surgery still competitive?

Ahmed S. Elmallah, Yehia M. Alkhateeb, Said I. Elmallah

Abstract


Background: There are different evolving minimally invasive surgical options for varicose veins (VV) treatment. This study compared Endo-venous Laser Ablation (EVLA) and foam sclerotherapy Vs high tie and multiple phlebectomy / ligation without vein stripping.

Methods: 185 lower limbs with primary VV and sapheno-femoral junction (SFJ)incompetence were included. Patients were divided into two groups. Group A: 85 limbs in 78 patients (4 had chronic venous ulcers) were treated by EVLA & foam sclerotherapy under tumescent anesthesia. Group B: 100 limbs in 100 patients (5 had chronic venous ulcers) were treated by high tie and multiple phlebectomy/ ligation under local anesthesia. All patients had duplex ultrasound preoperative and 4 weeks and 1 year postoperatively. Postoperative outpatient follow-up was 4 weeks, 3, 6 and 12 months.

Results: All procedures were successful. Early postoperative recurrence in 3 limbs (3.52%) in EVLA and no early recurrence in group B. Patients with venous ulcers healed within 3-5 weeks in both groups. Postoperative pigmentation was higher in group B. Mean time of procedure was 60-90 min and 60-150 min respectively. Significant pain in first week was more in group A (40 patients) than group B (22 patients) p<0.05. No DVT, wound infection, permanent nerve affection nor skin burn was recorded in both groups. Return to normal activities was quicker in Group B compared to group A but mean cost per limb was higher in Group B (1000 -1500 US $) versus Group A (500-750 US$).

Conclusions: Both procedures are effective and safe in treating varicose veins. Minimally invasive surgery was less costly, more postoperative pain and was associated with longer operative time. EVLA was associated with more postoperative pigmentation and 1 year VV recurrence.


Keywords


Endovenous ablation, Minimally invasive varicose veins surgery, Sapheno-femoral junction, Varicose veins

Full Text:

PDF

References


Lohr JM, Bush RL. Venous disease in women: Epidemiology, manifestations, and treatment. Send to J Vasc Surg. 2013;57(4 Suppl):37S-45S.

Gohel MS, Heatley F, Liu X, Bradbury A, Bulbulia R, Cullum N, et al. A randomized trial of early endovenous ablation in venous ulceration. N Engl J Med. 2018;378(22):2105-14.

Epstein D, Onida S, Bootun R, Ortega-Ortega M, Davies AH. Cost-Effectiveness of Current and Emerging Treatments of Varicose Veins. Value Health. 2018;21(8):911-20.

Brittenden J, Cotton SC, Elders A, Ramsay CR, Norrie J, Burr J, et al. A Randomized Trial Comparing Treatments for Varicose Veins. N Engl J Med. 2014;371(13):1218-27.

Jones L, Braithwaite BD, Selwyn D, Cooke S, Earnshaw JJ. Neovascularisation is the Principal Cause of Varicose Vein Recurrence: Results of a Randomised Trial of Stripping the Long Saphenous Vein. Eur J Vasc Endovasc Surg. 1996;12(4):442-5.

Brake M, Lim CS, Shepherd AC, Shalhoub J, Davies AH. Pathogenesis and etiology of recurrent varicose veins. J Vasc Surg. 2013;57(3):860-8.

Winterborn RJ, Foy C, Earnshaw JJ. Causes of varicose vein recurrence: Late results of a randomized controlled trial of stripping the long saphenous vein. J Vasc Surg. 2004;40(4):634-9.

Min RJ, Khilnani N, Zimmet SE. Endovenous laser treatment of saphenous vein reflux: long-term results. J Vasc Interv Radiol. 2003;14:991-6.

Proebstle T, Krummenauer F, Gul D, Knop J. Nonocclusion and early reopening of the great saphenous vein after endovenous laser treatmentis fluence dependent. Dermatol Surg. 2004;30:174-8.

Theivacumar N, Dellagrammaticas D, Beale R, Mavor AID, Gough MJ. The fate and clinical significance of sapheno-femoral junction tributaries following endovenous laser ablation of great saphenous vein. Br J Surg. 2007;94:722-75.

Gauw SA, Lawson JA, van Vlijmen-van Keulen CJ, Pronk P, Gaastra MT, Mooij MC. Five-year follow-up of a randomized, controlled trial comparing saphenofemoral ligation and stripping of the great saphenous vein with endovenous laser ablation (980 nm) using local tumescent anesthesia. J Vasc Surg. 2016;63(2):420-8.